151 related articles for article (PubMed ID: 1828201)
1. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].
Guidi L; Bartoloni C; Pellicanò P; Cappelli A; Cursi F; Pili R; Tricerri A; Patriarca F; Gambassi G
Clin Ter; 1991 Mar; 136(6):367-73. PubMed ID: 1828201
[TBL] [Abstract][Full Text] [Related]
2. [The thrombin-antithrombin III complex ELISA test in diagnosis of surgery-induced blood coagulation activation].
Kemen M; Sperling H; Mumme A; Zumtobel V
Infusionstherapie; 1991 Aug; 18(4):199-201. PubMed ID: 1937844
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
[TBL] [Abstract][Full Text] [Related]
4. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
Pelzer H; Schwarz A; Heimburger N
Thromb Haemost; 1988 Feb; 59(1):101-6. PubMed ID: 3363526
[TBL] [Abstract][Full Text] [Related]
5. The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems.
Elgue G; Pasche B; Blombäck M; Olsson P
Thromb Haemost; 1990 Jun; 63(3):435-8. PubMed ID: 2205949
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
[TBL] [Abstract][Full Text] [Related]
7. [The clinical applications of serum tumor markers in gastroenterology].
González Martínez M; Marín López E
Rev Gastroenterol Mex; 1993; 58(2):103-7. PubMed ID: 7747020
[TBL] [Abstract][Full Text] [Related]
8. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].
Zuazu-Jausoro I; Borrell M; Urrutia T; Oliver A; Montserrat I; Mateo J; Ribera L; Fontcuberta J
Sangre (Barc); 1990 Oct; 35(5):375-9. PubMed ID: 2291147
[TBL] [Abstract][Full Text] [Related]
9. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
10. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
Heimburger N; Pelzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):269-73. PubMed ID: 2465214
[TBL] [Abstract][Full Text] [Related]
11. Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.
Bartoloni C; Guidi L; Tricerri A; Patriarca F; Pili R; Cursi F; Canetta M; Cappelli A; Vangeli M; Salvati F
Oncology; 1992; 49(6):426-30. PubMed ID: 1465280
[TBL] [Abstract][Full Text] [Related]
12. Serum evaluation of soluble interferon-alpha/beta receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer.
Miyake K; Imura S; Nishioka M; Batmunkh E; Sugimoto K; Ohmoto Y; Shimada M
Cytokine; 2010 Mar; 49(3):251-5. PubMed ID: 19879773
[TBL] [Abstract][Full Text] [Related]
13. [Importance of the determination of thrombin-antithrombin-III complexes in hypercoagulability states].
García Avello A; García Frade A; Sureda JL; Torrado MC
Sangre (Barc); 1991 Apr; 36(2):163. PubMed ID: 1866654
[No Abstract] [Full Text] [Related]
14. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer].
Sawaguchi K; Hojo T; Nozaki S; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):73-8. PubMed ID: 1541865
[TBL] [Abstract][Full Text] [Related]
16. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
Malukiewicz-Wiśniewska G; Kotschy M
Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
[TBL] [Abstract][Full Text] [Related]
17. New trends in the field of coagulation diagnosis--new possibilities to improve monitoring of antithrombotic therapy.
Pelzer H; Stüber W; Dati F; Heimburger N
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):867-71. PubMed ID: 2483704
[TBL] [Abstract][Full Text] [Related]
18. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
19. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
20. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
